Owens & Minor, Inc. (NYSE:OMI) Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP cut its position in shares of Owens & Minor, Inc. (NYSE:OMI - Free Report) by 2.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,702,248 shares of the company's stock after selling 98,203 shares during the quarter. Dimensional Fund Advisors LP owned approximately 6.10% of Owens & Minor worth $61,457,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of OMI. Waldron Private Wealth LLC bought a new position in Owens & Minor in the 4th quarter worth approximately $406,000. JPMorgan Chase & Co. boosted its stake in Owens & Minor by 68.4% in the third quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company's stock worth $5,912,000 after buying an additional 152,999 shares in the last quarter. Advisors Preferred LLC raised its position in Owens & Minor by 173.9% in the 4th quarter. Advisors Preferred LLC now owns 84,305 shares of the company's stock worth $1,083,000 after purchasing an additional 53,529 shares during the period. Barclays PLC lifted its stake in shares of Owens & Minor by 354.8% in the 3rd quarter. Barclays PLC now owns 133,702 shares of the company's stock valued at $2,099,000 after acquiring an additional 104,305 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in Owens & Minor by 6.0% in the fourth quarter. Bank of New York Mellon Corp now owns 622,921 shares of the company's stock valued at $8,142,000 after purchasing an additional 35,105 shares during the last quarter. 98.04% of the stock is owned by hedge funds and other institutional investors.

Owens & Minor Trading Up 0.1 %

Shares of OMI stock traded up $0.01 during trading hours on Wednesday, reaching $7.72. 922,339 shares of the stock were exchanged, compared to its average volume of 1,112,913. The firm has a market capitalization of $596.41 million, a price-to-earnings ratio of -11.88, a price-to-earnings-growth ratio of 0.20 and a beta of 1.38. Owens & Minor, Inc. has a 12-month low of $6.07 and a 12-month high of $21.02. The company's 50-day moving average price is $8.23 and its 200-day moving average price is $10.90. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11.

Owens & Minor (NYSE:OMI - Get Free Report) last announced its earnings results on Friday, February 28th. The company reported $0.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.02. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The business had revenue of $2.70 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same quarter in the previous year, the business earned $0.69 earnings per share. The company's revenue for the quarter was up 1.5% compared to the same quarter last year. As a group, equities analysts anticipate that Owens & Minor, Inc. will post 1.51 earnings per share for the current year.

Owens & Minor declared that its board has approved a stock buyback program on Friday, February 28th that authorizes the company to repurchase $100.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 13.6% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's management believes its stock is undervalued.

Wall Street Analyst Weigh In

OMI has been the topic of a number of research analyst reports. UBS Group reduced their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Robert W. Baird increased their target price on Owens & Minor from $10.00 to $11.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. JPMorgan Chase & Co. reduced their price target on shares of Owens & Minor from $14.00 to $10.00 and set an "underweight" rating for the company in a research report on Monday, March 10th. Finally, Citigroup decreased their target price on Owens & Minor from $13.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, April 17th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, Owens & Minor currently has a consensus rating of "Hold" and an average price target of $12.50.

Insider Transactions at Owens & Minor

In other news, major shareholder Coliseum Capital Management, L acquired 225,000 shares of the firm's stock in a transaction that occurred on Wednesday, April 9th. The stock was purchased at an average cost of $7.39 per share, for a total transaction of $1,662,750.00. Following the completion of the acquisition, the insider now directly owns 11,482,955 shares of the company's stock, valued at $84,859,037.45. The trade was a 2.00 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Over the last ninety days, insiders have purchased 2,718,412 shares of company stock worth $24,495,308. Insiders own 3.69% of the company's stock.

Owens & Minor Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.